Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia

Article abstract of DOI:10.1111/jnc.14660

Cerebral ischemia is the second most common cause of death and a major cause of disability worldwide. Available therapies are based only on anticoagulants or recombinant tissue plasminogen activator. Extracellular adenosine increases during ischemia and a